= 60, p < .001. All patients received 30 tablets of only one opioid prescription upon discharge with no refill, either oxycodone-IR (82%, n = 49), hydromorphone (5%, n = 3), or tramadol (12%, n = 7). The project, aimed to reduce opioid overprescription and overconsumption, has the potential to improve prescribing practices, promoting patient safety and healthcare quality by supporting the current guidelines that recommend against using ER opioids for the study population.
Keyphrases
- patient safety
- healthcare
- chronic pain
- end stage renal disease
- pain management
- ejection fraction
- primary care
- quality improvement
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- prognostic factors
- risk assessment
- patient reported outcomes
- social media
- estrogen receptor
- human health
- drug induced
- health information
- breast cancer cells